Publication & Citation Trends
Publications
0 total
Does Adjuvant Immune Checkpoint Inhibition Therapy Have a Future in Operable Bladder Cancer?
Cited by 1
Semantic Scholar
Perioperative Durvalumab in Bladder Cancer. Reply.
Cited by 1
Semantic Scholar
Belzutifan in Europe: A New Targeted Therapy for Clear Cell Renal Cancer.
Cited by 2
Semantic Scholar
Antibody-Drug Conjugates in Combination Therapy: Defining the Next Chapter.
Cited by 2
Semantic Scholar
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types.
Cited by 10
Semantic Scholar
Anti-VEGF and -PD-1 Combinations in Renal Cell Carcinoma: When Are Treatment Breaks Safe?
Cited by 0
Semantic Scholar
Landscape of subsequent therapies in perioperative immunotherapy trials across multiple cancer types.
Cited by 1
Semantic Scholar
Annals of Oncology - passing the baton, raising the bar.
Cited by 0
Semantic Scholar
Research Topics
Bladder and Urothelial Cancer Treatments
(441)
Cancer Immunotherapy and Biomarkers
(321)
Urinary and Genital Oncology Studies
(232)
Renal cell carcinoma treatment
(121)
Cancer Genomics and Diagnostics
(80)
Affiliations
Université Paris-Sud
Universitat Autònoma de Barcelona
National Health Service
Novartis (Switzerland)
Guy's Hospital